We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Groundbreaking Test Could Detect Prostate Cancer Within Minutes Via Urine Sample

By LabMedica International staff writers
Posted on 25 Dec 2024

In the UK, over 52,000 men are diagnosed with prostate cancer annually, with up to one-quarter of these cases identified at a later stage, requiring more intensive treatments. More...

The cost to the NHS for these extensive treatments alone amounts to GBP 650 million. If detected early, prostate cancer is treatable before symptoms develop. However, current prostate-specific antigen (PSA) blood tests lack sufficient accuracy to serve as an effective screening tool, creating a need for a more reliable and convenient method for detection. A pioneering new test now offers the potential to detect prostate cancer in men more quickly and accurately than existing methods.

Valley Diagnostics (Cardiff, UK) is developing a lateral flow test that could detect prostate cancer in minutes from a urine sample, making it possible to conduct the test in a GP surgery or even at home. The company aims to roll out this test as part of a nationwide prostate cancer screening program in the UK that could help save thousands of lives and save the NHS millions of pounds each year. The OSCAR clinical study, a collaborative project involving Aberystwyth University (Aberystwyth, UK), is screening thousands of urine samples from men with prostate cancer across 12 hospitals in England and Wales. The study has identified several key biomarkers in the urine of prostate cancer patients, offering significantly better diagnostic accuracy compared to the existing PSA blood test used by the NHS.

Valley Diagnostics holds exclusive commercialization rights for these biomarker discoveries and is partnering with scientists at Aberystwyth University to develop a cost-effective and accurate lateral flow test based on urine samples. This rapid, accurate point-of-care screening test could enable healthcare systems to diagnose prostate cancer more quickly and effectively, leading to improved patient outcomes. The company is currently seeking funding through equity and grants to continue developing a prototype of the lateral flow test.

“This has the potential to completely transform the way we test for prostate cancer, saving thousands of lives and easing the pressure on the NHS,” said Dave Taylor, CEO of Valley Diagnostics. “It is cost-effective and reliable, providing immediate results that allow for effective patient triage without the need for additional lab testing. This could reduce patient stress and inconvenience, cut costs, and eliminate unnecessary waiting times and clinical visits.”

“The biomarkers we have found will allow us to develop a groundbreaking test that could be used in a GP surgery or even at home,” added Professor Luis Mur, who heads the OSCAR study at Aberystwyth University. “We expect this will lead to a paradigm shift in prostate cancer detection which could save lives. The increased accuracy of this test could prevent men undergoing unnecessary treatments and save the NHS money.”

Related Links:
Valley Diagnostics
Aberystwyth University


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.